Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?

Chronic leg ulcers (CLUs) are full thickness wounds that usually occur between the ankle and knee, fail to heal after 3 months of standard treatment, or are not entirely healed at 12 months. CLUs present a considerable burden on patients, subjecting them to severe pain and distress, while healthcare...

Full description

Bibliographic Details
Main Authors: Christos Kyriakidis, Ferdinand Lali, Karin Vicente Greco, Elena García-Gareta
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/8/5/62
id doaj-8f3274eddea64bdd8637c7a33c71e715
record_format Article
spelling doaj-8f3274eddea64bdd8637c7a33c71e7152021-05-31T23:36:59ZengMDPI AGBioengineering2306-53542021-05-018626210.3390/bioengineering8050062Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?Christos Kyriakidis0Ferdinand Lali1Karin Vicente Greco2Elena García-Gareta3Regenerative Biomaterials Group, The RAFT Institute & The Griffin Institute, Northwick Park and Saint Mark’s Hospital, London HA1 3UJ, UKThe Griffin Institute, Northwick Park and Saint Mark’s Hospital, London HA1 3UJ, UKThe Griffin Institute, Northwick Park and Saint Mark’s Hospital, London HA1 3UJ, UKRegenerative Biomaterials Group, The RAFT Institute & The Griffin Institute, Northwick Park and Saint Mark’s Hospital, London HA1 3UJ, UKChronic leg ulcers (CLUs) are full thickness wounds that usually occur between the ankle and knee, fail to heal after 3 months of standard treatment, or are not entirely healed at 12 months. CLUs present a considerable burden on patients, subjecting them to severe pain and distress, while healthcare systems suffer immense costs and loss of resources. The poor healing outcome of the standard treatment of CLUs generates an urgent clinical need to find effective solutions for these wounds. Tissue Engineering and Biomaterials Science offer exciting prospects for the treatment of CLUs, using a broad range of skin substitutes or scaffolds, and dressings. In this review, we summarize and discuss the various types of scaffolds used clinically in the treatment of CLUs. Their structure and therapeutic effects are described, and for each scaffold type representative examples are discussed, supported by clinical trials. Silver dressings are also reviewed due to their reported benefits in the healing of leg ulcers, as well as recent studies on new dermal scaffolds, reporting on clinical results where available. We conclude by arguing there is a further need for tissue-engineered products specifically designed and bioengineered to treat these wounds and we propose a series of properties that a biomaterial for CLUs should possess, with the intention of focusing efforts on finding an effective treatment.https://www.mdpi.com/2306-5354/8/5/62leg ulcerschronic woundsdiabetic foot ulcerstissue engineeringdermal scaffolds
collection DOAJ
language English
format Article
sources DOAJ
author Christos Kyriakidis
Ferdinand Lali
Karin Vicente Greco
Elena García-Gareta
spellingShingle Christos Kyriakidis
Ferdinand Lali
Karin Vicente Greco
Elena García-Gareta
Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
Bioengineering
leg ulcers
chronic wounds
diabetic foot ulcers
tissue engineering
dermal scaffolds
author_facet Christos Kyriakidis
Ferdinand Lali
Karin Vicente Greco
Elena García-Gareta
author_sort Christos Kyriakidis
title Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
title_short Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
title_full Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
title_fullStr Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
title_full_unstemmed Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
title_sort chronic leg ulcers: are tissue engineering and biomaterials science the solution?
publisher MDPI AG
series Bioengineering
issn 2306-5354
publishDate 2021-05-01
description Chronic leg ulcers (CLUs) are full thickness wounds that usually occur between the ankle and knee, fail to heal after 3 months of standard treatment, or are not entirely healed at 12 months. CLUs present a considerable burden on patients, subjecting them to severe pain and distress, while healthcare systems suffer immense costs and loss of resources. The poor healing outcome of the standard treatment of CLUs generates an urgent clinical need to find effective solutions for these wounds. Tissue Engineering and Biomaterials Science offer exciting prospects for the treatment of CLUs, using a broad range of skin substitutes or scaffolds, and dressings. In this review, we summarize and discuss the various types of scaffolds used clinically in the treatment of CLUs. Their structure and therapeutic effects are described, and for each scaffold type representative examples are discussed, supported by clinical trials. Silver dressings are also reviewed due to their reported benefits in the healing of leg ulcers, as well as recent studies on new dermal scaffolds, reporting on clinical results where available. We conclude by arguing there is a further need for tissue-engineered products specifically designed and bioengineered to treat these wounds and we propose a series of properties that a biomaterial for CLUs should possess, with the intention of focusing efforts on finding an effective treatment.
topic leg ulcers
chronic wounds
diabetic foot ulcers
tissue engineering
dermal scaffolds
url https://www.mdpi.com/2306-5354/8/5/62
work_keys_str_mv AT christoskyriakidis chroniclegulcersaretissueengineeringandbiomaterialssciencethesolution
AT ferdinandlali chroniclegulcersaretissueengineeringandbiomaterialssciencethesolution
AT karinvicentegreco chroniclegulcersaretissueengineeringandbiomaterialssciencethesolution
AT elenagarciagareta chroniclegulcersaretissueengineeringandbiomaterialssciencethesolution
_version_ 1721417070784020480